Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study

American Journal of Epidemiology

Volumn 163, Issue 12, 2006, Pages 1084-1090

  Pope, Sandra K ^a   Kritchevsky, Stephen B ^b   Ambrosone, Christine ^c   Yaffe, Kristine ^d   Tylavsky, Frances ^e   Simonsick, Eleanor M ^f   Rosano, Caterina ^g   Stewart, Scott ^h   Harris, Tamara ^f  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cognition; Ethnic groups; Peroxidase; Polymorphism, genetic; Prospective studies

Indexed keywords

MYELOPEROXIDASE;

AGING; ANTIMICROBIAL ACTIVITY; COGNITION; DISEASE PREVALENCE; ENZYME; FREE RADICAL; GENOTYPE; HEALTH CARE; NEUROLOGY; POLYMORPHISM;

AGED; ALZHEIMER DISEASE; ARTICLE; BODY COMPOSITION; BRAIN TISSUE; COGNITIVE DEFECT; ENZYME POLYMORPHISM; FEMALE; GENDER; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOPEROXIDASE GENE; PROMOTER REGION; RACE; RISK FACTOR; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANALYSIS OF VARIANCE; BODY COMPOSITION; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; PEROXIDASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES;

MEMPHIS; NORTH AMERICA; PENNSYLVANIA; PITTSBURGH; TENNESSEE; UNITED STATES;

EID: 33745625361     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj146     Document Type: Article

References (25)

1. Geula C, Wu CK, Saroff D, et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 1998;4:827-31.
2. Akama KT, Albanese D, Pestell RG, et al. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci U S A 1998;95:5795-800.
3. Klegeris A, McGeer PL. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997;49:229-35.
4. Wetle T. Living longer, aging better. JAMA 1997;278:1376-7.
5. Green PS, Mendez AJ, Jacob JS, et al. Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem 2004;90:724-33.
6. Reynolds WF, Rhees J, Maciejewski D, et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol 1999;155:31-41.
7. Piedrafita FJ, Molander RB, Vansant G, et al. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996;271:14412-20.
8. Crawford FC, Freeman MJ, Schinka JA, et al. Association between Alzheimer's disease and a functional polymorphism in the myeloperoxidase gene. Exp Neurol 2001;167:456-9.
9. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
10. Reynolds WF, Hiltunen M, Pirskanen M, et al. MPO and APOEe4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 2000;55:1284-90.
11. Combarros O, Infante J, Llorca J, et al. The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis. Neurosci Lett 2002;326:33-6.
12. Harris TB, Visser M, Everhart J, et al. Waist circumference and sagittal diameter reflect total body fat better than visceral fat in older men and women. Ann N Y Acad Sci 2000;904:462-73.
13. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-42.
14. Bravo G, Hevert R. Age- and education-specific reference values for the Mini-Mental and Modified Mini-Mental State Examinations derived from a non-demented elderly population. Int J Geriatr Psychiatry 1997;12:1008-18.
15. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-18.
16. McDowell I, Kristjansson B, Hill GB, et al. Community screening for dementia: the Mini-Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol 1997;50:377-83.
17. Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med 1993;25:391-5.
18. SAS Institute, Inc. SAS/STAT user guide, version 8, 4th ed, vol 2. Cary, NC: SAS Institute, Inc, 1999.
19. Styczynska M, Religa D, Pfeffer A, et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 2003;344:99-102.
20. Leininger-Muller B, Hoy A, Herbeth B, et al. Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study. Neurosci Lett 2003;349:95-8.
21. Hoy A, Lieninger-Muller B, Poirier O, et al. Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. Atherosclerosis 2003;167:223-30.
22. Zappia M, Manna I, Serra P, et al. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Arch Neurol 2004;61:341-4.
23. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
24. Pope SK, Shue VM, Beck C. Will a healthy lifestyle help prevent Alzheimer's disease? Annu Rev Public Health 2004;24:111-32.
25. Fraser PE, Nguyen JT, Chin DT, et al. Effects of sulfate icons in Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem 1992;59:1531-40.